| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |